Device type · OZZ
Bordetella Pertussis Dna Assay System
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
OZZ
Microbiology
Device class
Class II
FDA decisions since 2015
7
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 21, 2026
How FDA classifies it
- Device type
- Bordetella Pertussis Dna Assay System
- Product code
- OZZ
- Device class
- Class II
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3980
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for OZZ
Latest FDA decisions
K243753 · Decided Nov 20, 2025 · 350 days after receipt
Device type: Bordetella Pertussis Dna Assay System (OZZ) · Laboratory Medicine & Pathology
6 more FDA decisions with a free account
Reports received
0
Received Nov 1, 2025 to Nov 21, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Ortho-Clinical Diagnostics, Inc.
Z-1948-2025 · Started Mar 24, 2025 · Posted by FDA Jun 11, 2025
Reason given: It was determined that there could be a false positive rate of up to 16.7% for the affected lots associated with the Bordetella parapertussis (BPP) results (only) of the assay.
Cause as FDA categorized it: Under Investigation by firm
1 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.